2006
DOI: 10.1007/s00428-006-0245-y
|View full text |Cite
|
Sign up to set email alerts
|

Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey

Abstract: To measure discrepancies in diagnoses and recommendations impacting management of proliferative lesions of the breast, a questionnaire of five problem scenarios was distributed among over 300 practicing pathologists. Of the 230 respondents, 56.5% considered a partial cribriform proliferation within a duct adjacent to unequivocal ductal carcinoma in situ (DCIS) as atypical ductal hyperplasia (ADH), 37.7% of whom recommended reexcision if it were at a resection margin. Of the 43.5% who diagnosed the partially in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
1
5

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 27 publications
2
18
1
5
Order By: Relevance
“…Most of the studies investigating concordance rates documented that high interobserver variation was mostly due to problems in differentiating atypical ductal hyperplasia and low-grade ductal carcinoma in situ. 8,11,[19][20][21][22] The category specific k-value was lowest for atypical ductal hyperplasia (0.43 for stages 1 and 2) in this study. These results are similar to studies by Palli et al 8 and MacGrogan et al, 23 with the lowest category specific k-values for the diagnosis of atypical ductal hyperplasia (0.38 and 0.36, respectively).…”
Section: Discussioncontrasting
confidence: 49%
See 1 more Smart Citation
“…Most of the studies investigating concordance rates documented that high interobserver variation was mostly due to problems in differentiating atypical ductal hyperplasia and low-grade ductal carcinoma in situ. 8,11,[19][20][21][22] The category specific k-value was lowest for atypical ductal hyperplasia (0.43 for stages 1 and 2) in this study. These results are similar to studies by Palli et al 8 and MacGrogan et al, 23 with the lowest category specific k-values for the diagnosis of atypical ductal hyperplasia (0.38 and 0.36, respectively).…”
Section: Discussioncontrasting
confidence: 49%
“…These results are still within the range of observations seen in prior studies. [7][8][9][10][11][18][19][20] The preselection of difficult/challenging cases could also have had a significant impact on the results of the study. This is illustrated by the low number of cases (11%) with complete agreement, as well as the low intraobserver agreement in stages 1 and 2 of the study.…”
Section: Discussionmentioning
confidence: 99%
“…The subjectivity of interpreting breast lesions when quantitative criteria are used (atypical ductal hyperplasia versus ductal carcinoma in situ and papilloma versus papilloma with atypia or papillary carcinoma) has been well addressed in the pathology literature. [18][19][20] The cases that were discrepant in our study were the types of lesions that generally cause variability in interpretation. It is to be noted that variability in the histologic interpretations, which resulted from failure to recognize focal tissue changes or changes in the final categorization between reads, occurred in both WSI and OM.…”
Section: Commentmentioning
confidence: 67%
“…Elles doivent par conséquent faire l'objet d'une exérèse avec repérage compte tenu de la fréquence des lésions invasives associées. ces lésions histologiques à risque sont toutes des • marqueurs de risque de survenue de cancer du sein homo-ou controlatéral par rapport à la population générale [53] ; le RR est majoré par d'autres facteurs : âge, antécé-• dents familiaux (modèle de Gail) ; la décision thérapeutique repose sur une prise en • charge pluridisciplinaire ; la diffi culté dans l'indication chirurgicale réside • dans le risque de sous-évaluation mais aussi de surtraitement ; malgré l'introduction de critères « anatomopatho-• logiques », il existe toujours une grande variabilité interobservateur [59,112]. L'apport récent de la biologie moléculaire peut contribuer à la caractérisation de ces lésions pour adapter la prise en charge théra-peutique dans un contexte multidisciplinaire…”
Section: Dossierunclassified